biafw: the income statement

MyFinsight

bioAffinity Technologies, Inc. (BIAFW)

For the quarter ending 2025-06-30, BIAFW made $1,269,483 in revenue. -$4,060,787 in net income. Net profit margin of -319.88%.

Unit: Dollar

	2025-06-30
Net revenue	1,269,483
Selling, general and administrative	2,214,561
Research and development	311,372
Depreciation and amortization	113,229
Direct costs and expenses	1,016,602
Clinical development	129,279
Total operating expenses	3,785,043
Loss from operations	-2,515,560
Other income	38,053
Other expense	483,043
Interest income	2,025
Interest expense	10,460
Change in fair value of warrants issued	1,062,818
Total other income (expense), net	-1,516,243
Net loss before provision for income tax expense	-4,031,803
Income tax expense	28,984
Net loss	-4,060,787

Net loss per common share, basic	-0.17
Net loss per common share, diluted	-0.17
Weighted average common shares outstanding, basic	24,021,546
Weighted average common shares outstanding, diluted	24,021,546

Unit: Dollar